Crispr Genomic Cure Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type, By Therapy Type, By Delivery Method, By End User, By Targeted Genetic Modification, By Region & Competition, 2020-2030F

Description

Global Crispr Genomic Cure Market was valued at USD 2.95 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 25.15% through 2030. The global CRISPR genomic cure market is a rapidly evolving sector within the biotechnology and healthcare industries. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionized gene editing and holds immense promise for treating various genetic and hereditary diseases.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.95 Billion
Market Size 2030	USD 11.36 Billion
CAGR 2025-2030	25.15%
Fastest Growing Segment	Genetic Disorders
Largest Market	North America

Key Market Drivers

Increasing Prevalence of Genetic Disorders and Chronic Diseases

The growing incidence of genetic disorders and chronic diseases is a major driver behind the rapid expansion of the Global CRISPR Genomic Cure Market. Genetic disorders and congenital abnormalities affect approximately 2%-5% of all live births, contributing to up to 30% of pediatric hospital admissions and accounting for nearly 50% of childhood mortality in industrialized nations. These figures highlight a critical demand for advanced genomic interventions, positioning CRISPR-based therapies as a transformative solution in pediatric healthcare. As the burden of hereditary and chronic illnesses continues to rise worldwide, there is an increasing demand for innovative, targeted, and long-term solutions to treat these conditions. CRISPR-based gene editing has emerged as a groundbreaking approach, offering precise and potentially curative treatments for diseases with a strong genetic basis. The incidence of genetic disorders and chronic diseases is increasing due to factors such as aging populations, environmental influences, and inherited genetic mutations. Annually,

Key Market Challenges

Ethical and Regulatory Hurdles

Perhaps one of the most significant challenges is the ethical and regulatory landscape surrounding CRISPR technology. The ethical debate over gene editing in humans, particularly germline editing, remains a contentious issue. Regulatory agencies worldwide are grappling with the need to strike a balance between fostering innovation and ensuring safety and ethical considerations.

Key Market Players

Merck KGaA
Takara Bio Inc
Lonza Group AG
Horizon Discovery Group Ltd
Genscript Biotech Corp
Synthego Corp
Precision BioSciences Inc
Mammoth Biosciences Inc
Thermo Fisher Scientific Inc
Intellia Therapeutics Inc

Report Scope:

In this report, the Global Crispr Genomic Cure Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Crispr Genomic Cure Market, By Disease Type:

Genetic Disorders
Cancer
Infectious Diseases
Neurological Disorders
Cardiovascular Disorders
Blood Disorders
Metabolic Disorders
Others

Crispr Genomic Cure Market, By Therapy Type:

Gene Editing
Gene Therapy
Cell Therapy
Immunotherapy

Crispr Genomic Cure Market, By Delivery Method:

In vivo
Ex vivo

Crispr Genomic Cure Market, By End User:

Hospitals & Clinics
Research Institutes
Biotechnology & Pharmaceutical Companies

Crispr Genomic Cure Market, By Targeted Genetic Modification:

Single Gene Modification
Multiple Gene Modification
Genome-wide Modification

Crispr Genomic Cure Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Crispr Genomic Cure Market.

Available Customizations:

Global Crispr Genomic Cure market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Crispr Genomic Cure Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Disease Type (Genetic Disorders, Cancer, Infectious Diseases, Neurological Disorders, Cardiovascular Disorders, Blood Disorders, Metabolic Disorders, Others)
- 5.2.2. By Therapy Type (Gene Editing, Gene Therapy, Cell Therapy, Immunotherapy)
- 5.2.3. By Delivery Method (In vivo, Ex vivo)
- 5.2.4. By End User (Hospitals & Clinics, Research Institutes, Biotechnology & Pharmaceutical Companies)
- 5.2.5. By Targeted Genetic Modification (Single Gene Modification, Multiple Gene Modification, Genome-wide Modification)
- 5.2.6. By Region
- 5.2.7. By Company (2024)
5.3. Market Map

6. North America Crispr Genomic Cure Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Disease Type
- 6.2.2. By Therapy Type
- 6.2.3. By Delivery Method
- 6.2.4. By End User
- 6.2.5. By Targeted Genetic Modification
- 6.2.6. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Crispr Genomic Cure Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Disease Type
    - 6.3.1.2.2. By Therapy Type
    - 6.3.1.2.3. By Delivery Method
    - 6.3.1.2.4. By End User
    - 6.3.1.2.5. By Targeted Genetic Modification
- 6.3.2. Canada Crispr Genomic Cure Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Disease Type
    - 6.3.2.2.2. By Therapy Type
    - 6.3.2.2.3. By Delivery Method
    - 6.3.2.2.4. By End User
    - 6.3.2.2.5. By Targeted Genetic Modification
- 6.3.3. Mexico Crispr Genomic Cure Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Disease Type
    - 6.3.3.2.2. By Therapy Type
    - 6.3.3.2.3. By Delivery Method
    - 6.3.3.2.4. By End User
    - 6.3.3.2.5. By Targeted Genetic Modification

7. Europe Crispr Genomic Cure Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Disease Type
- 7.2.2. By Therapy Type
- 7.2.3. By Delivery Method
- 7.2.4. By End User
- 7.2.5. By Targeted Genetic Modification
- 7.2.6. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Crispr Genomic Cure Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Disease Type
    - 7.3.1.2.2. By Therapy Type
    - 7.3.1.2.3. By Delivery Method
    - 7.3.1.2.4. By End User
    - 7.3.1.2.5. By Targeted Genetic Modification
- 7.3.2. United Kingdom Crispr Genomic Cure Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Disease Type
    - 7.3.2.2.2. By Therapy Type
    - 7.3.2.2.3. By Delivery Method
    - 7.3.2.2.4. By End User
    - 7.3.2.2.5. By Targeted Genetic Modification
- 7.3.3. Italy Crispr Genomic Cure Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Disease Type
    - 7.3.3.2.2. By Therapy Type
    - 7.3.3.2.3. By Delivery Method
    - 7.3.3.2.4. By End User
    - 7.3.3.2.5. By Targeted Genetic Modification
- 7.3.4. France Crispr Genomic Cure Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Disease Type
    - 7.3.4.2.2. By Therapy Type
    - 7.3.4.2.3. By Delivery Method
    - 7.3.4.2.4. By End User
    - 7.3.4.2.5. By Targeted Genetic Modification
- 7.3.5. Spain Crispr Genomic Cure Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Disease Type
    - 7.3.5.2.2. By Therapy Type
    - 7.3.5.2.3. By Delivery Method
    - 7.3.5.2.4. By End User
    - 7.3.5.2.5. By Targeted Genetic Modification

8. Asia-Pacific Crispr Genomic Cure Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Disease Type
- 8.2.2. By Therapy Type
- 8.2.3. By Delivery Method
- 8.2.4. By End User
- 8.2.5. By Targeted Genetic Modification
- 8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Crispr Genomic Cure Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Disease Type
    - 8.3.1.2.2. By Therapy Type
    - 8.3.1.2.3. By Delivery Method
    - 8.3.1.2.4. By End User
    - 8.3.1.2.5. By Targeted Genetic Modification
- 8.3.2. India Crispr Genomic Cure Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Disease Type
    - 8.3.2.2.2. By Therapy Type
    - 8.3.2.2.3. By Delivery Method
    - 8.3.2.2.4. By End User
    - 8.3.2.2.5. By Targeted Genetic Modification
- 8.3.3. Japan Crispr Genomic Cure Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Disease Type
    - 8.3.3.2.2. By Therapy Type
    - 8.3.3.2.3. By Delivery Method
    - 8.3.3.2.4. By End User
    - 8.3.3.2.5. By Targeted Genetic Modification
- 8.3.4. South Korea Crispr Genomic Cure Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Disease Type
    - 8.3.4.2.2. By Therapy Type
    - 8.3.4.2.3. By Delivery Method
    - 8.3.4.2.4. By End User
    - 8.3.4.2.5. By Targeted Genetic Modification
- 8.3.5. Australia Crispr Genomic Cure Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Disease Type
    - 8.3.5.2.2. By Therapy Type
    - 8.3.5.2.3. By Delivery Method
    - 8.3.5.2.4. By End User
    - 8.3.5.2.5. By Targeted Genetic Modification

9. South America Crispr Genomic Cure Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Disease Type
- 9.2.2. By Therapy Type
- 9.2.3. By Delivery Method
- 9.2.4. By End User
- 9.2.5. By Targeted Genetic Modification
- 9.2.6. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Crispr Genomic Cure Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Disease Type
    - 9.3.1.2.2. By Therapy Type
    - 9.3.1.2.3. By Delivery Method
    - 9.3.1.2.4. By End User
    - 9.3.1.2.5. By Targeted Genetic Modification
- 9.3.2. Argentina Crispr Genomic Cure Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Disease Type
    - 9.3.2.2.2. By Therapy Type
    - 9.3.2.2.3. By Delivery Method
    - 9.3.2.2.4. By End User
    - 9.3.2.2.5. By Targeted Genetic Modification
- 9.3.3. Colombia Crispr Genomic Cure Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Disease Type
    - 9.3.3.2.2. By Therapy Type
    - 9.3.3.2.3. By Delivery Method
    - 9.3.3.2.4. By End User
    - 9.3.3.2.5. By Targeted Genetic Modification

10. Middle East and Africa Crispr Genomic Cure Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Disease Type
- 10.2.2. By Therapy Type
- 10.2.3. By Delivery Method
- 10.2.4. By End User
- 10.2.5. By Targeted Genetic Modification
- 10.2.6. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Crispr Genomic Cure Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Disease Type
    - 10.3.1.2.2. By Therapy Type
    - 10.3.1.2.3. By Delivery Method
    - 10.3.1.2.4. By End User
    - 10.3.1.2.5. By Targeted Genetic Modification
- 10.3.2. Saudi Arabia Crispr Genomic Cure Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Disease Type
    - 10.3.2.2.2. By Therapy Type
    - 10.3.2.2.3. By Delivery Method
    - 10.3.2.2.4. By End User
    - 10.3.2.2.5. By Targeted Genetic Modification
- 10.3.3. UAE Crispr Genomic Cure Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Disease Type
    - 10.3.3.2.2. By Therapy Type
    - 10.3.3.2.3. By Delivery Method
    - 10.3.3.2.4. By End User
    - 10.3.3.2.5. By Targeted Genetic Modification

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Crispr Genomic Cure Market: SWOT Analysis

14. Competitive Landscape

14.1. Merck KGaA
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (If Listed)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
14.2. Takara Bio Inc
14.3. Lonza Group AG
14.4. Horizon Discovery Group Ltd
14.5. Genscript Biotech Corp
14.6. Synthego Corp
14.7. Precision BioSciences Inc
14.8. Mammoth Biosciences Inc
14.9. Thermo Fisher Scientific Inc
14.10.Intellia Therapeutics Inc.